OppenheimerFunds’s Chemed CHE Stock Holding History

OppenheimerFunds’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.02M	Buy	3,193 +650	+26%	+$200K	﹤0.01%	1058
2018 Q4	$720K	Buy	2,543 +701	+38%	+$212K	﹤0.01%	1195
2018 Q3	$589K	Sell	1,842 -28	-1%	-$8.92K	﹤0.01%	1371
2018 Q2	$602K	Sell	1,870 -1,804	-49%	-$565K	﹤0.01%	1346
2018 Q1	$1M	Sell	3,674 -1,602	-30%	-$424K	﹤0.01%	1061
2017 Q4	$1.28M	Sell	5,276 -669	-11%	-$152K	﹤0.01%	1072
2017 Q3	$1.2M	Sell	5,945 -25	-0.4%	-$4.92K	﹤0.01%	1108
2017 Q2	$1.22M	Sell	5,970 -594	-9%	-$118K	﹤0.01%	1100
2017 Q1	$1.2M	Buy	6,564 +334	+5%	+$58.2K	﹤0.01%	1111
2016 Q4	$999K	Buy	6,230 +894	+17%	+$131K	﹤0.01%	1103
2016 Q3	$753K	Sell	5,336 -259	-5%	-$36.1K	﹤0.01%	1102
2016 Q2	$763K	Buy	5,595 +598	+12%	+$79.3K	﹤0.01%	1088
2016 Q1	$677K	Sell	4,997 -630	-11%	-$85.2K	﹤0.01%	1119
2015 Q4	$843K	Buy	+5,627	New	+$832K	﹤0.01%	1093

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

OppenheimerFunds's CHE Position: Q1 2019 in Review

OppenheimerFunds increased its Chemed (CHE) stake by 26% in Q1 2019, buying an estimated $200K and bringing the position to 3,193 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1058.

OppenheimerFunds first reported a position in CHE in Q4 2015 and has held it in 14 quarters since. The position peaked at $1.28M in Q4 2017. 382 funds tracked by Wall St. Rank hold CHE as of Q1 2019.

OppenheimerFunds held 3,193 shares of Chemed worth $1.02M as of Q1 2019.
OppenheimerFunds bought 650 Chemed shares in Q1 2019, an estimated $200K.
Chemed made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1058 holding.
OppenheimerFunds first reported a position in Chemed in Q4 2015 and has held it in 14 quarters since.
OppenheimerFunds's Chemed position peaked at $1.28M in Q4 2017.
382 funds tracked by Wall St. Rank held Chemed as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.